Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
25.03. | Contractors WuXi Bio, WuXi XDC eye continued growth after logging solid performances in 2024 | ||
25.03. | Trump again threatens tariffs on pharmaceuticals in 'not too distant' future | ||
25.03. | AstraZeneca, Pfizer rebuked over breaking UK drug marketing rules on LinkedIn use | ||
24.03. | Eyeing blockbuster sales, Harmony names Takeda veteran Zaeske chief commercial officer | ||
24.03. | Gavi terminates COVID vaccine deal with Clover, demands $224M repayment | ||
24.03. | After Starboard Value gets a seat on the board, another activist investor rallies for change at Kenvue: Bloomberg | ||
24.03. | Novo Nordisk offers cheaper Wegovy for all cash-paying patients at retail pharmacy | ||
24.03. | Biogen plots 2028 headquarters shift to new 'innovation hub' in Cambridge | ||
24.03. | Bharat Biotech enters cell and gene therapy market with $75M production investment: reports | ||
21.03. | FDA rejects Hengrui, Elevar's PD-1 cancer drug combination-again | ||
21.03. | Novartis links music and science in corporate campaign tied to Eurovision sponsorship | ||
21.03. | J&J touts $55B in planned US investments over 4 years, including 3 new manufacturing sites | ||
21.03. | Novartis snags FDA nod for Fabhalta in another kidney disease but leaves room for rival Apellis | ||
20.03. | Lilly backs study in mission to improve Hollywood representations of obesity, diabetes, dementia and more | ||
20.03. | Paratek acquires Optinose, rhinosinusitis spray Xhance in deal worth up to $330M | ||
20.03. | Investor group calls for strategy shift as Amarin shares continue to flounder post-Sarissa Capital takeover | ||
20.03. | Calling UK 'uninvestable,' pharma giants demand revamp of drug cost control policy | ||
20.03. | South Africa's Aspen hit with warning letter chiding the continent's largest drugmaker over sterility issues | ||
19.03. | CDMO Delpharm gets cash infusion from Canada to help modernize former Sandoz injectables plant | ||
19.03. | Pfizer enlists Elizabeth Banks for Gen X-focused pneumococcal vaccine push | ||
19.03. | Amid Trump's push to abolish DEI, Roche and Novartis adjust hiring initiatives: reports | ||
19.03. | Purdue Pharma files new $7.4B bankruptcy reorganization plan to settle opioid claims | ||
19.03. | Pfizer pockets roughly £2.5B as it shaves off final stake in consumer health spinoff Haleon | ||
19.03. | 'Pick Up Your Poop': A potty-mouthed dog flips the script in Exact-backed cancer screening PSA | ||
18.03. | Aadi Bioscience takes flight with new moniker: Whitehawk Therapeutics |